Apixaban dose reduction to 2.5 mg twice daily appeared safe after 6 months of full-dose treatment for venous thromboembolism among patients with cancer, according to a study published in Journal ...

The HEAL-COVID trial compared the efficacy of Apixaban to standard care in adults who have recently recovered from severe COVID-19.

The aim of the API-CAT trial was to assess whether the lower dose of apixaban was comparable to the full dose in preventing VTE recurrence in patients with active cancer who had completed at least ...

Eliquis is used to treat and prevent blood clots in certain people. Learn about its recommended dosages, how to take it, and more.

Patients with active cancer who developed a blood clot, or venous thromboembolism (VTE), and were treated with blood-thinning medication for at least six months, followed by an additional 12 ...

Contrary to some clinical observations, aspirin and apixaban (Eliquis) do not reduce the rate of major adverse cardiovascular or pulmonary outcomes in stable outpatients with symptomatic COVID-19 ...

Venous thromboembolism: Less recurrencies with low-dose apixaban compared to discontinuation of the anticoagulant after negative D-dimer The Apidulcis management study Reports and Proceedings ...

The risk for GI bleeding was reduced for low-dose apixaban vs low-dose rivaroxaban (Xarelto), suggested the analysis of more than half a million patients with AF taking one of four DOACs for ...

Treatment assignments were either low-dose DOAC (apixaban 2.5 mg twice a day) or standard DAPT for 3 months.

A follow-up analysis on a National Institutes of Health-funded clinical trial found that daily aspirin use increases the risk of anemia by 20% in older adults who are otherwise healthy.

Low-dose birth control pills contain less estrogen and progestin than other birth control pills. Learn the potential benefits and side effects.